Medtronic Announces Formation of New Cardiovascular Surgery Business Unit Through Merger of Cardiac Surgery and Aortic Businesses
Medtronic
Medical Device Manufacturer
May 6,MedtronicAnnounced an important organizational restructuring on social media: the merger of its two business units, Cardiac Surgery and Aortic, to officially form"Cardiovascular Surgery"Division. This move marks a further step in the strategic integration of this global medical technology giant in the cardiovascular field.Confirmation of the New Division Leader
According to official information, the cardiovascular surgery division after this merger will be led by Karim Bandali, the former head of the cardiac surgery business, as its president. Bandali publicly announced this news on LinkedIn, stating:"Today, we are officially merging the Cardiac Surgery and Aortic businesses — both teams possess deep expertise and outstanding talent, and are jointly committed to serving patients and clinicians."
Meanwhile, Simona Zannetti, the former head of aortic operations, left Medtronic earlier this year and has taken on the role of Chief Medical Officer and Senior Vice President of Clinical Research at Artivion.
Product Line Coverage After Integration
The new cardiovascular surgery division integrates the rich product lines of two major business segments. The cardiac surgery business covers surgical heart valves, extracorporeal membrane oxygenation (ECMO), left atrial appendage occlusion (LAA occlusion), mitral and tricuspid valve repair technologies, etc.; the aortic business includes interventional devices such as stent grafts and guidewires.
Bandali emphasized in the statement: "By integrating our capabilities, we have gained a powerful opportunity to accelerate innovation, strengthen collaboration with doctors and care teams, and make a greater impact across the entire continuum of cardiovascular care. Our daily focus is to serve more patients today than yesterday by clearly concentrating on Medtronic's mission."
Not the First Business Unit Merger
Notably, this merger is not Medtronic's first business unit integration. Since the company underwent a strategic reorganization in 2020 and established 20 business units, organizational restructuring has occurred multiple times. In 2023, Medtronic merged its surgical robotics business with the Surgical Innovations business to form a standalone Surgical business unit; in 2024, it further consolidated the Patient Monitoring and Respiratory Interventions businesses into the "Acute Care & Monitoring (ACM)" business unit while exiting the ventilator market.
This ongoing business integration reflects Medtronic's strategic intent to continuously optimize resource allocation and focus on core growth areas in the complex medical technology field.
Core ViewpointMedtronic Aims to Integrate Complementary Technology Platforms by Merging Cardiac Surgery and Aortic Businesses, Strengthening Its Comprehensive Solution Capabilities Across the Entire Field of Cardiovascular Surgery, and Continuously Promoting Organizational Efficiency.
Copyright Statement: This platform aims to help healthcare professionals better understand the latest developments in relevant disease areas. The information published on this platform does not imply agreement with its descriptions or viewpoints; it is solely for providing more information. If there are any copyright issues, we kindly request the rights holders to contact us, and we will address them as soon as possible. This information is intended exclusively for healthcare professionals to stay informed, and such information should not replace professional medical guidance in any way, nor should it be regarded as medical advice. If such information is used for purposes other than staying informed, this platform and its authors shall not bear any related responsibilities.Contact email for collaboration:vascular@edoctor.work。
